Shaw Souradet, Plourde Pierre, Klassen Penny, Stein Derek
Institute for Global Public Health, Department of Community Health Sciences, University of Manitoba, Winnipeg, MB.
Population and Public Health, Winnipeg Regional Health Authority, Winnipeg, MB.
Can Commun Dis Rep. 2022 Feb 24;48(2-3):95-101. doi: 10.14745/ccdr.v48i23a07.
In 2018, Manitoba had the highest reported rate of infectious syphilis in Canada, at over three times the national average. Infectious syphilis in Manitoba is centred on young, marginalized heterosexual couples in Winnipeg's inner-city. Subsequently, a public health crisis involving congenital syphilis emerged in Manitoba, just prior to the coronavirus disease 2019 pandemic. Testing and screening (in the case of pregnancy) for syphilis is thought to be an effective measure to reduce the incidence of syphilis and its sequelae. The aim of this study is to describe syphilis testing practices in the general population and amongst pregnant women, during a period of shifting syphilis epidemiology.
We used population-based syphilis testing data from Cadham Provincial Laboratory (Winnipeg, Manitoba) for 2015 to 2019. Directly age-standardized rates are reported, and Poisson regression used to model the determinants of testing rates. Rates of prenatal screening are also reported.
From 2015 to 2019, a total of 386,350 individuals were tested for syphilis. The rate increased annually, from 462 per 10,000 population in 2015 to 704 per 100,000 in 2019, while the female-to-male ratio decreased from 1.8 to 1.6. Prior to 2019, the majority of pregnant women (approximately 60%) were screened once, during the first trimester; however, 2019 saw more women having more than two tests during the course of their pregnancy.
An overall increase in the number of individuals tested was observed, reflecting the increased rate of syphilis in Manitoba. Prenatal screening patterns shifted in 2019, likely in response to rising congenital syphilis numbers.
2018年,曼尼托巴省报告的感染性梅毒发病率在加拿大最高,超过全国平均水平的三倍。曼尼托巴省的感染性梅毒集中在温尼伯市中心区年轻、边缘化的异性恋夫妇中。随后,在2019年冠状病毒病大流行之前,曼尼托巴省出现了一场涉及先天性梅毒的公共卫生危机。梅毒检测和筛查(针对怀孕情况)被认为是降低梅毒发病率及其后遗症的有效措施。本研究的目的是描述在梅毒流行病学发生变化的时期,普通人群和孕妇中的梅毒检测情况。
我们使用了2015年至2019年来自卡德姆省级实验室(曼尼托巴省温尼伯市)基于人群的梅毒检测数据。报告了直接年龄标准化率,并使用泊松回归对检测率的决定因素进行建模。还报告了产前筛查率。
2015年至2019年,共有386,350人接受了梅毒检测。检测率逐年上升,从2015年的每10,000人462例增至2019年的每100,000人704例,而女性与男性的比例从1.8降至1.6。2019年之前,大多数孕妇(约60%)在孕早期接受过一次筛查;然而,2019年有更多女性在孕期接受了两次以上检测。
观察到检测人数总体增加,反映出曼尼托巴省梅毒发病率上升。2019年产前筛查模式发生了变化,可能是对先天性梅毒病例数上升的应对措施。